logo
Select company
Select metric
$ -114.89MEarning Before Interest & Taxes (EBIT)
VS
Market
9
Sector
18
Industry
25
History
58
$ 1.85Close
$ 0.41 - $ 2.18 52-Week Range
Ticker Information

Ticker

ALXO

Company Name

ALX ONCOLOGY HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ALX ONCOLOGY HOLDINGS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ALXO - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -114.89M
3/31/2025$ -128.31M
12/31/2024$ -133.12M
9/30/2024$ -149.44M
6/30/2024$ -169.78M
3/31/2024$ -164.6M
12/31/2023$ -159.24M
9/30/2023$ -144.83M
6/30/2023$ -129.55M
3/31/2023$ -128.68M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ALX ONCOLOGY HOLDINGS INC's latest trailing twelve months (TTM) EBIT stands at $ -44.69M.
  • Over the past 5 years, ALX ONCOLOGY HOLDINGS INC's average EBIT has been $ -115.02M.
  • The median EBIT for ALX ONCOLOGY HOLDINGS INC during this period was $ -123.42M
  • ALX ONCOLOGY HOLDINGS INC reached its highest EBIT over the past 5 years at $ -44.69M.
  • The lowest EBIT recorded by ALX ONCOLOGY HOLDINGS INC in the same timeframe $ -169.78M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

ALXO - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -169.78M

Minimum

Jun 30, 2024

$ -44.69M

Maximum

Dec 31, 2020

$ -115.02M

Average

$ -123.42M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.81M with a standard deviation of $ 130.86M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 443M
average$ 28.81M
median$ 1.05M
std$ 130.86M